Related Experiment Video
Updated: Jan 16, 2026

08:26
Behavioral And Physiological Analysis In A Zebrafish Model Of Epilepsy
Published on: October 19, 2021
6.2K
Vaccinations and Dravet Syndrome
1Pediatric Neurology, Department of Pediatrics, University Hospitals of Geneva, Geneva, Switzerland.
Pediatric Neurology Briefs
|March 3, 2016
Summary
Vaccinations did not increase seizure risk or alter the disease course in children with Dravet syndrome (DS). This study offers reassurance regarding vaccine safety for this vulnerable population.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Dravet syndrome (DS) is a rare, severe form of epilepsy in infants.
- Concerns exist regarding the safety of vaccinations in children with epilepsy, particularly DS.
- Understanding vaccine effects is crucial for managing DS patients.
Purpose of the Study:
- To investigate the impact of routine vaccinations on seizure frequency and severity in patients with Dravet syndrome.
- To assess whether vaccinations affect the overall disease progression in individuals with DS.
- To provide evidence-based information for healthcare providers and parents regarding DS vaccination.
Main Methods:
- Retrospective analysis of medical records from Dutch epilepsy centers and public health institutions.
- Inclusion of patients diagnosed with Dravet syndrome.
- Evaluation of vaccination status and correlation with seizure events and disease milestones.
Main Results:
- No significant increase in seizure frequency or severity was observed post-vaccination.
- Vaccinations did not appear to negatively influence the long-term disease course of Dravet syndrome.
- Analysis included a cohort of patients from diverse healthcare settings.
Conclusions:
- Routine vaccinations are considered safe for children with Dravet syndrome.
- The findings suggest that vaccination does not exacerbate epilepsy in DS patients.
- This study supports current vaccination guidelines for individuals with Dravet syndrome.
Related Concept Videos
Drug Dosing: Infants and Children
255
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
255
Vaccinations
51.3K
Overview
51.3K
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
827
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
827
Seizures: Classification
1.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Cancer Vaccines
972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972

